CECR 2018 – Programme

FromUntilActivityAuthors
11.0020.00Registration
12.0012.30Pre-congress refreshment
12.3013.30Opening ceremony
13.3014.00Invited plenary lecture
Influence of Mediterranean diet on incidence and course of inflammatory rheumatic diseases.
Maurizio Cutolo (ITA)
14.0015.30Section I - host country Croatia
Epidemiology of SLE in Central Europe

Chair persons:
Branimir Anić, Srđan Novak
Invited speakers
14.0014.20 Causes of early and late death and survival of SLE patients over a 10-year period: analysis from a Croatian tertiary center.Ivan Padjen, Mislav Cerovec, Miroslav Mayer, Marko Barešić, Dubravka Bosnić, Mirna Sentić, Marijan Erceg, Ranko Stevanović, Branimir Anić
14.2014.40Disease activity and damage index in 110 SLE patients.Felina Anić, Srđan Novak
14.4015.00Ultrasound evaluation of the ankle joints and tendons in systemic lupus erythematosus.Ljiljana Smiljanić Tomičević, Darija Čubelić, Miroslav Mayer
Oral presentations
15.0015.10The differences between clinical manifestations and comorbidities between women and men with SLE treated in University Hospital of Split from January 2007 to December 2017.Daniela Marasović Krstulović, Leona Žuvan, Dijana Perković, (HRV)
15.1015.20Childhood-onset systemic lupus erythematosus over the last 25 years: predicting organ damage.Nastasia Čekada, Mario Šestan, Emilija Hostička, Maja Novoselec, Mateja Batnožić Varga, Ivan Padjen, Marijan Frković, Domagoj Kifer, Branimir Anić, Drago Batinić, Kristina Potočki, Ivan Malčić, Marija Jelušić, (HRV)
15.2015.30Cognitive dysfunction in systemic lupus erythematosus is more associated with non-inflammatory mechanism than inflammation.Veronika Balajková, Radka Moravcová, Marta Olejárová, (CZE)
15.3015.45Break
15.4517.15 Section II - host country Austria
Topic: Rheumatoid arthritis - beyond the disease

Chair persons:
Rudolf Puchner, Klaus Machold
Invited speakers
15.4516.05Rheumatoid arthritis and female sexual dysfunction.Judith Sautner
16.0516.25Rheumatoid arthritis – psyche and depression.Rudolf Puchner
16.2516.45 Comorbidities in rheumatoid arthritis.Helga Radner
Oral presentations
16.4516.55 Myocardial necrosis caused by systemic vasculitis or atherosclerosis in rheumatoid arthritis – A postmortem clinicopathologic study of 161 patients.Bély Miklós, Apáthy Ágnes, (HUN)
16.5517.05Disease activity and treatment patterns in patients with rheumatoid arthritis in Croatia.Joško Mitrović, Katarina Borić, Simeon Grazio, Frane Grubišić, Željka Kardum, Tatjana Kehler, Nikolina Ljubičić Marković, Daniela Marasović-Krstulović, Ksenija Maštrović-Radončić, Sonja Milanović, Višnja Prus, Ivana Tomljanović Rudar, Jadranka Morović-Vergles, (HRV)
17.0517.15Difficult to treat - a patient with rheumatoid arthritis and T-cell large granular lymphocyte leukemia (T-LGLL).Krešimir Rukavina, Goran Šukara, Branimir Anić, (HRV)
17.1517.45 Break for refreshment
17.4518.45Industry sponsored symposia:
1. Eli Lilly (Suisse) S.A.
2. Sanofi - Aventis Hrvatska d.o.o.
18.4519.15Break
19.1522.00Welcome reception
FromUntilActivityAuthors
07.3020.00Registration
07.4509.15Section III - host country Slovenia
Topic: Giant Cell Arteritis

Chair persons:
Alojzija Hočevar, Iztok Holc
Invited speakers
07.4508.05Giant cell arteritis - an overview.Alojzija Hočevar
08.0508.25Early diagnosis of giant cell arteritis - does it matter?Iztok Holc, Metka Koren Krajnc, Artur Pahor
08.2508.45 Colour doppler sonography of facial and occipital arteries in patients with giant cell arteritis.Rok Ješe, Žiga Rotar, Matija Tomšič, Alojzija Hočevar
Oral presentations
08.4508.55Giant cell arteritis in Poland. How to increase diagnostic rate?Marcin Milchert, Marek Brzosko, (POL)
08.5509.05The occurrence of paraneoplastic syndromes in patients with polymyalgia rheumatica treated at the University Hospital Center Osijek.Ana Marija Lukinac, Željka Kardum, Ivana Kovačević, Jasminka Milas-Ahić, Višnja Prus, (HRV)
09.05 09.15Diagnosis and management of patients with granulomatosis with polyangiitis.Eugene J. Kucharz (POL)
09.1509.30Break
09.3010.30 Industry sponsored symposia:
3. Celgene d.o.o.
4. Merck Sharp & Dohme d.o.o.
10.3011.00Break for refreshment
11.0012.30Section IV - host country Hungary
Topic: Advances in inflammatory myopathies and systemic sclerosis

Chair persons:
Laszlo Czirjak, Emese Kiss
Invited speakers
11.0011.10MRI in evaluation of inflammatory myopathy.Jiří Vencovský, Kateřina Kubínová, (CZE)
11.1011.20Novel classification of inflammatory myopathies.Zoltan Griger
11.2011.30Survival and subset classification analysis of 82 patients with inflammatory myopathy.Cecília Varjú, Katinka Gulyás, Tünde Minier, Tímea Berki, László Czirják, Endre Pál
11.3011.40Biomarkers and activity markers in scleroderma.Attila Balog
11.4011.50 Osteoporosis in systematic sclerosis. Szilvia Szamosi
11.5012.00Novel factors associated with cyclophosphamide efficacy in autoimmune diseases.Melinda Szabo
Oral presentations
12.0012.10Clinical course of systemic sclerosis patients.Monika Chrzanowska, Magdalena Włoch-Targońska, Przemysław Kotyla, Eugeniusz Józef Kucharz, (POL)
12.1012.20HSP90 plasma sevels are increased in patients with systemic sclerosis especially with interstitial lung involvement and skin fibrosis.Hana Storkanova (CZE), Sabina Oreska (CZE), Maja Spiritovic (CZE), Barbora Hermankova (CZE), Karel Pavelka (CZE), Jiri Vencovsky (CZE), Joerg HW Distler (GER), Ladislav Senolt (CZE), Radim Becvar (CZE), Michal Tomcik, (CZE)
12.2012.30Impaired sexual functioning in women with systemic sclerosis.Barbora Heřmánková (CZE)
12.3014.00Poster viewing and poster tours
12.3014.00Boxed lunch
14.0015.30Section V - host country Poland
Topic: Specific aspects of SpA

Chair persons:
Eugen J. Kucharz, Hanna Przepiera-Bedzak
Invited speakers
14.0014.20Innate immune system in the pathogenesis of spondyloarthritis – monocytes involvement.Marius Korkosz
14.2014.40Risk factors for extra-articular signs in spondyloarthritis.Hanna Przepiera-Bedzak, Marek Brzosko
14.4015.00SAPHO syndrome – clinical symptoms, imaging and treatment – based on a group of Polish patients.Hanna Przepiera-Bedzak, Marek Brzosko
Oral presentations
15.0015.10Abberancies of specific peripheral blood T-cell and monocyte subpopulations in ankylosing spondilitis correlate with disease activity parameters. Alan Šućur, Zrinka Jajić, Marina Ikić Matijašević, Marinko Artuković, Darja Flegar, Tomislav Kelava, Nina Lukač, Antonio Markotić, Danka Grčević, (HRV)
15.1015.20Plasma levels of HSP90 are increased in axial spondyloarthritis and psoriatic arthritis patients with structural changes. Hana Storkanova, Kristyna Bubova, Sabina Oreska, Maja Spiritovic, Barbora Hermankova, Monika Gregova, Katerina Zegzulkova, Jana Horinkova, Karel Pavelka, Jiri Vencovsky, Jiri Stolfa, Marketa Husakova, Sarka Forejtova, Ladislav Senolt, Michal Tomcik, (CZE)
15.2015.30Which demographic disease related variables may be predictors of quality of life in psoriatic arthritis patients?Frane Grubišić, Hana Skala Kavanagh, Ines Doko, Jure Aljinović, Tonko Vlak, Petra Kovačević, Simeon Grazio, (HRV)
15.3015.45Break for refreshment
15.4516.45 Industry sponsored symposia
5. Novartis Hrvatska d.o.o.
6. Pfizer Croatia d.o.o.
16.4517.00Technical break
17.0019.00Young rheumatologists section
17.0017.20 The incidence rate and clinical characteristics of rheumatoid arthritis in Slovenia.Katja Perdan-Pirkmajer (SVN)
17.2017.40Validation of SLICC-12 and ACR-97 classification criteria in a patient cohort with SLE treated in University Hospital Centre Zagreb. Marija Bakula (HRV)
17.4018.00Social media use for health-related purposes by people with rheumatic and musculoskeletal diseases. Paul Studenic (AUT)
18.0018.20Increase in non-classical subpopulations of monocytes and decrease in numbers of NK cells in the pre-clinical phase of rheumatoid arthritis. Maria Filkova (CZE)
18.2018.40Hemophagocytic lymphohistiocytosis. Magdalena Wloch-Targonska (POL)
18.4019.00Responsiveness of articular disease activity indices in patients with systemic sclerosis. Veronika Lorand (HUN)
20.0022.30Congress dinner
FromUntilActivityAuthors
08.0020.00Registration
08.00
09.30Section VI - host country Slovakia
Topic: Imaging in Rheumatology

Chair persons:
Martin Zlnay, Zdenko Killinger
Invited speakers
08.0008.20Highlights and pitfalls of MRI imaging in axial spondyloarthritis patients.Martin Zlnay
08.2008.40Importance of trabecular bone score in fracture risk prediction in rheumatoid arthritis and ankylosing spondylitis.Zdenko Killinger
08.4009.00Temporomandibular joint arthritis and the role of imaging.Tomáš Dallos, Juraj Lysý
Oral presentations
09.0009.10Comparison of computerized color telethermography and nailfold capillaroscopy in diagnostics of secondary Raynaud's phenomenon in children. Mario Sestan, Natasia Cekada, Daniel Turudic, Mateja Batnozic Varga, Jagoda Stipic, Marko Baresic, Marijan Frkovic, Domagoj Kifer, Marija Jelusic, (HRV)
09.1009.20Application of FRAX and trabecular bone score in patients with psoriatic arthritis. Simeon Grazio, Frane Grubišić, Hana Skala Kavanagh, Ines Doko, Rudolf Vukojević, Lora Bolić, Luciana Mijačika, Marija Punda, (HRV)
09.2009.30Progression of pain, stiffness, function changes, and ultrasound detected synovitis and osteophyte formation in patients with hand osteoarthritis over three years. Olga Sleglova, Olga Ruzickova, Karel Pavelka, Ladislav Šenolt, (CZE)
09.3009.45Break for refreshment
09.4510.45Industry sponsored symposia
7. Oktal Pharma d.o.o. Celltrion Healthcare
8. Mylan Hrvatska d.o.o.
11.0012.30Section VII - host country Czech Republic
Topic: Biomarkers in Rheumatology

Chair persons:
Jiří Vencovský, Ladislav Šenolt
Invited speakers
11.0011.20 Biomarkers in rheumatology, what do we really know?Ladislav Šenolt
11.2011.40Biomarkers in axial spondyloarthritis.Kristyna Bubova, Ladislav Šenolt
11.4012.00MiRNAs as biomarkers in autoimmune rheumatic diseases.Maria Filkova
Oral presentations
12.0012.10Expression of CXCL16 in peripheral blood of individuals in the pre-clinical phase of rheumatoid arthritis.Klára Prajzlerová, Olga Kryštůfková, Petra Hánová, Hana Hulejová, Monika Gregová, Karel Pavelka, Jiří Vencovský, Ladislav Šenolt, Mária Filková, (CZE)
12.1012.20Investigating the potential of mean lymphocyte volume and mean monocyte volume as biochemical markers for diagnosis and follow up of rheumatoid arthritis and ankylosing spondylitis.Sara Sekelj (UK), Branimir Žarković (HRV), Miroslav Mayer (HRV), Renata Zadro (HRV), Marija Miloš, (HRV)
12.2012.30Plasma levels of HSP90 are increased in rheumatoid arthritis and osteoarthritis patients. Kristyna Bubova, Hana Storkanova, Sabina Oreska, Maja Spiritovic, Barbora Hermankova, Karel Pavelka, Jiri Vencovsky, Jindriska Gatterova, Ladislav Senolt, Michal Tomcik, (CZ)
12.3013.00Final remarks and closing of the Congress
13.0014.00Boxed lunch
Poster presentations will be held on Friday 7th

Poster numberTopicPresenters
P1 Advances in management of systemic lupus erythematosus.Jozef Lukáč, Oľga Lukáčová, (SVK)
P2 When a rheumatologic disease gets a head start. A case report of seronegative antiphospholipid syndrome. Marta Skoczynska, Malgorzata Chowaniec, Agata Sebastian, Maria Misterska – Skora, Piotr Wiland, (POL)
P3 Neutrophil to lymphocyte ratio (NLR) in patients with systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA).Antica Pasarić, Branimir Anić, Ivan Marković, Ivan Padjen, Jadranka Morović-Vergles, (HRV)
P4 Deficiency of marginal-zone-like B cell absolute values in peripheral blood in systemic lupus erythematosus – a twelve-month follow-up study.Zbynek Hrncir, Doris Vokurkova, Marcela Drahosova, Tomas Soukup, (CZE)
P5 Relationship between renal and cardiac AA amyloidosis in rheumatoid arthritis – A comparative postmortem clinicopathologic study of 161 patients.Bély Miklós, Apáthy Ágnes, (HUN)
P6 Efficacy of biologic treatment on quality of life in rheumatoid arthritis patients in Croatia: results from a non-interventional, multicenter, cross-sectional study to estimate disease activity and treatment patterns in patients with rheumatoid arthritis.Frane Grubišić, Simeon Grazio, Katarina Borić, Željka Kardum, Tatjana Kehler, Daniela Marasović Krstulović, Nikolina Ljubičić Marković, Sonja Milanović, Jadranka Morović Vergles, Joško Martinović, Višnja Prus, Ksenija Maštrović Radačić, Ivana Rudar Tomljanović, (HRV)
P7 Association between ICF brief core set for hand conditions and grip strength in rheumatoid arthritis patients. Ines Doko, Frane Grubišić, Hana Skala Kavanagh, Simeon Grazio, (HRV)
P8 Association of rs17004921 ADORA2A gene polymorphism with efficacy of methotrexate in patients with rheumatoid arthritis. Vera Milić, Milka Grk, Biljana Jekić, Nela Maksimović, Ivana Maksimović, Nemanja Damjanov, (SRB)
P9 Treatment options in patient with rheumatoid arthritis and history of malignancy – intracranial chondrosarcoma /osteochondroma. Ivana Ježić, Marko Barešić, Luka Simetić, Davorin Herceg, Branimir Anić, (HRV)
P10 The association between patient reported outcomes and clinical measures among rheumatoid arthritis patients: analyses using phase 3 clinical trials of upadacitinib. Vibeke Strand (USA), Nemanja Damjanov (SRB), Craig Scoville (USA), Namita Tundia (USA), Heidi Camp (USA), Kun Chen (USA), Jessica L Suboticki (USA), Ronald F van Vollenhoven (NLD)
P11 A phase 3, randomized controlled trial comparing upadacitinib monotherapy to MTX monotherapy in MTX-naïve patients with active rheumatoid arthritis.Ronald F van Vollenhoven (NLD), Tsutomu Takeuchi (JPN), Aileen L Pangan (USA), Mohamed-Elsam F Mohamed (USA), Su Chen (USA), Maureen Rischmueller (AUS), Ricardo Blanco (ESP), Alan Friedman (USA), RIcardo M Xavier (BRA), Vibeke Strand (USA)
P12 A phase 3, randomized, double-blind study comparing upadacitinib to placebo and to adalimumab, in patients with active rheumatoid arthritis with inadequate response to methotrexate.Roy Fleischmann (USA), Aileen L Pangan (USA), Eduardo Mysler (ARG), Louis Bessette (CAN), Charles Peterfy (USA), Patrick Durez (BEL), Andrew Ostor (AUS), Yihan Li (USA), Yijie Zhou (USA), Ahmed A Othman (USA), Ih-Ho Song (USA), Mark C Genovese (USA)
P13 The efficacy of subcutaneous application of tocilizumab in a patient with long standing large vessel vasculitis relapse, a case report.Marija Ščepović Ljucović, Dubravka Bosnić, (HRV)
P14 Childhood-onset of Henoch-Schönlein purpura nephritis in croatia: a study conducted in five tertiary care centres over nine years.Mateja Batnožić Varga, Natasia Čekada, Mario Šestan, Saša Sršen, Lucija Ružman, Maja Zaninović, Aleksandar Ovuka, Ivana Oždanovac, Marija Pečnjak, Domagoj Kifer, Marijan Frković, Alenka Gagro, Marija Jelušić, (HRV)
P15 Anemia and systemic sclerosis: frequency and clinic features.Roman Yatsyshyn, Bohdana Doskaliuk, (UKR)
P16 Potential markers of skin fibrosis in systemic sclerosis.Radim Bečvář (CZE)
P17 Inflammation-related proteins as potential markers of disease activity in patients with systemic sclerosis. Andrea Smržová (CZE)
P18 Systemic sclerosis and immunoglobulin therapy: our experience in the last 5 years.Dijana Perković, Marin Petrić, Ivona Božić, Daniela Marasović Krstulović, Katarina Borić, Dušanka Martinović Kaliterna, (HRV)
P19 Efficacy of an intensive 24-week physical-occupational therapy program with subsequent 24-week follow-up in patients with systemic sclerosis - preliminary data from a single-center controlled study. Maja Spiritovic, Hana Smucrova, Sabina Oreska, Hana Storkanova, Barbora Hermankova, Petr Cesak, Adela Rathouska, Olga Ruzickova, Karel Pavelka, Ladislav Senolt, Jiri Vencovsky, Radim Becvar, Michal Tomcik, (CZE)
P20 Differences in body composition in scleroderma patients and healthy controls and association with disease activity, physical activity and serum levels of inflammatory cytokines.Sabina Oreska, Maja Spiritovic, Petr Cesak, Michal Cesak, Hana, Storkanova, Hana Smucrova, Barbora Hermankova, Barbora Sumova, Olga Ruzickova, Herman Mann, Karel Pavelka, Ladislav Senolt, Jiri Vencovsky, Radim Becvar, Michal Tomcik, (CZE)
P21 Impaired sexual functioning in women with idiopathic inflammatory myopathies.Barbora Heřmánková (CZE)
P22 Negative changes of body composition in myositis patients compared to healthy controls and associations with myositis-related clinical manifestations. Sabina Oreska, Maja Spiritovic, Petr Cesak, Ondrej Marecek, Hana Storkanova, Hana Smucrova, Barbora Hermankova, Katerina Kubinova, Martin Klein, Lucie Vernerova, Olga Ruzickova, Karel Pavelka, Ladislav Senolt, Herman Mann, Jiri Vencovsky, Michal Tomcik, (CZE)
P23 Efficacy of an intensive 24-week specialized ADL exercise program with subsequent 24-week follow-up in patients with idiopathic inflammatory myopathies - preliminary data from a single-center controlled study. Maja Spiritovic, Sabina Oreska, Hana Storkanova, Barbora Hermankova, Petr Cesak, Adela Rathouska, Katerina Kubinova, Martin Klein, Lucia Vernerova, Olga Ruzickova, Herman Mann, Karel Pavelka, Ladislav Senolt, Jiri Vencovsky, Michal Tomcik, (CZE)
P24 Ocular manifestations in ankylosing spondylitis and rheumatoid arthritis.Ana Gudelj Gračanin, Joško Pavan, Ana Marija Valetić, Jadranka Morović Vergles, (HRV)
P25 The relationship between HLA-B27 and ocular involvement in male Albanian patients with ankylosing spondylitis.Mikel Jordhani, Dorina Ruci, (ALB)
P26 Anti-JAK treatment and infection in a patient with spondyloarthritis.Mirjam Szabo (HUN)
P27 Spontaneous biceps femoris rupture hematoma with secondary inflammation in a patient with psoriatic arthritis treated with secukinumab developing myelodysplastic syndrome (MDS) – case report. Lorena Petrač, Miroslav Mayer, (HRV)
P28 Inhibition of IL-17 by secukinumab lead to the remission of severe psoriatic arthritis and symptoms of pemphigus vulgaris in a patient concidence of these conditions. Marta Olejárová (CZE)
P29 Apremilast as a treatment of choice for psoriatic arthritis in a patient with difficult to treat autoimmune hepatitis. Mislav Čaić , Miroslav Mayer, Ivana Knežević Štromar, (HRV)
P30 Innate immunity gene expression signature in patients with autoimmune diseases in active disease stage: RA, SLE, SSc.Pavel Horák (CZE)
P31 S100A11 (calgizzarin) induces inflammation via TLR-4 signalling and stimulates secretion of angiogenic factors IL-8 and VEGFs by mononuclear cells in rheumatoid arthritis.Lucie Andrés Cerezo (CZE)
P32 Interaction of p.Q141K variant in ABCG2 gene with clinical data and cytokines levels in primary hyperuricemia and gout.Jana Bohatá, Veronika Horváthová, Kateřina Pavelcová, Blanka Stibůrková, (CZE)
P33 Real life experience with golimumab in Croatia.Felina Anić, Tatjana Kehler, Marija Rogoznica, Frane Grubišić, Simeon Grazio, Marta Žuvić, Srđan Novak, (HRV)
P34 Efficacy and safety of switching from oral to subcutaneous methotrexate in everyday clinical practice: results of the six-month observational prospective study in Croatia.Simeon Grazio, Dijana Perković, Ana Gudelj Gračanin, Nadica Laktašić Žerjavić, Marija Glasnović, Frane Grubišić, Jadranka Morović-Vergles, Porin Perić, Iva Žagar, Helena Mitrović, Petra Šimac, Željka Kolak, Ines Doko, (HRV)
P35 Infections and malignancies in patients treated with biological disease modifying antirheumatic drugs- our experience.Kristina Kovač Durmiš, Mislav Pap, Duje Birkić, Nadica Laktašić Žerjavić, Iva Žagar, Porin Perić, (HRV)
P36 Clinical outcomes of macrophage activation syndrome in University Hospital Centre.Tatjana Zekić, Ita Hadžisejdić, Srđan Novak, (HRV)
P37 Lyme disease. Most frequent observed symptoms. Is arthralgia among them?Agnė Petrulionienė, Daiva Radzišauskienė, Arvydas Ambrozaitis, Saulius Čaplinskas, Algimantas Paulauskas, Algirdas Venalis, (LTU)
P38 TRAPS (Tumor necrosis factor receptor- associated periodic syndrome).Oľga Lukáčová, Jozef Lukáč, (SVK)
P39 The relationship between the duration of methotrexate / etanercept therapy and serum anti-SPP IgG antibodies in patients with JIA without systemic manifestations.Margarita Soloshenko, Ekaterina Alexeevna, Rina Denisovna, Tatyana Dvoryakovskaya, Ksenia Isaeva, Anna Mamutova, Nikolay Mayansky, Natalyaya Tkachenko, Irina Zubkova, Marina Fedoseenko, (RUS)
P40 Structure modification in OA and present and future perspectives.Karel Pavelka (CZE)
P41 Hypokalemic paralysis as a presenting manifestation of primary Sjögren's syndrome: case report.Sonja Golubović (SRB)
P42 A rheumatologic disease or a paraneoplastic syndrome with a rheumatic manifestation? Case report.Marta Skoczynska, Malgorzata Chowaniec, Beata Maciazek – Chyra, Piotr Wiland, (POL)
P43 Severe course of polyarteritis nodosa presenting with asynchronous spontaneous retroperitoneal hemorrhage and spontaneous hepatic rupture: case report and literature review.Dubravka Bosnić, Hrvoje Barić, Mirna Reihl Crnogaj, Ivan Padjen, Savko Dobrota, Dražen Jelašić, Branimir Anić, (HRV)
P44 Aseptic systemic abscesses syndrome – case report.Lorena Petrač, Miroslav Mayer, (HRV)
P45 Arthritis of the ankles as a major manifestation of Poncet’s disease – case report. Marina Barguil Macedo, Alexandre Lima Matos, Edgard Torres dos Reis Neto, (BRA)
P46 Generalized telangiectasia misinterpreted as vasculitis- case report.Željka Kardum, Marija Šola, Jasminka Milas Ahić, Marta Biljan, Ana Kovač, Ana Marija Lukinac, Ivana Kovačević, Kristina Stranski Kovačević, Višnja Prus, (HRV)
P47 Educational expectations of the Polish patients with rheumatic disorders treated with biopharmaceuticals.Anna Kotulska-Kucharz (POL)
FromUntilActivityModerator
13.3015.30Writing and publishing scientific articleAY Gasparyan, S Grazio

Please review the full Post-Congress Workshop programme
The Post-Congress Workshop will be held on December 8th.

Registration fee for workshop „Writing and publishing scientific article“ is separated from the registration fee for CECR 2018. Registrations are based on the „first come – first served“ principle.
Due to limited number of places (25 participants) please make your registration on time. Workshop is primary aimed at younger colleagues.